The Use of Neutrophil Gelatinase Associated Lipocalin (NGAL) As A Novel Marker in Early Diagnosis of Hepatorenal Syndrome in Advanced Cirrhotic Patients

STUDY OF URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IN PATIENTS WITH LIVER CIRRHOSIS AND ITS RELATION TO HEPATORENAL SYNDROME

NEUTROPHIL GELATINASE–ASSOCIATED LIPOCALIN (NGAL) AS AN EARLY BIOMARKER OF ACUTE KIDNEY INJURY IN HEPATIC PATIENTS

Urinary Neutrophil Gelatinase-Associated Lipocalin as Predictor for Development of Hepatorenal Syndrome in Patients with Hepatic Cirrhosis

Urinary Neutrophil Gelatinase Associated lipocalin (NGAL) as A Biomarker of Acute Kidney Injury in Patients with Liver Cirrhosis

Neutrophil gelatinase-associated lipocalin (NGAL) role in diagnosis of complications of liver cirrhosis

Neutrophil gelatinase associated lipocalin: a new marker for early diagnosis of acute kidney injury in ICU

Predictability of at-admission Plasma Neutrophil Gelatinase– associated Lipocalin (NGAL) Level for Acute Kidney Injury in Patients admitted to Surgical Intensive Care Unit

Plasma and Urine Neutrophil Gelatinase-Associated Lipocalin (NGAL) as Early Predictor of Acute Kidney Injury in Septic Patients

Neutrophil gelatinase-associated lipocalin and oxidative stress markers based -scores to improve the diagnostic accuracy of chronic kidney diseases